Aglaia Schiza

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Metastatic Breast Cancer

Angiotensin Converting Enzyme

Diffusion Weighted

Top Venues

Breast cancer research and treatment

Scientific reports

JNCI cancer spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Carina Strell, Daniel Robert Smith, Antonis Valachis, Hellén Woldeyesus, Charlotta Wadsten, Patrick Micke, Irma Fredriksson, Aglaia Schiza
Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study. Breast cancer research and treatment (2024)
Carina Strell, Daniel Robert Smith, Antonis Valachis, Hellén Woldeyesus, Charlotta Wadsten, Patrick Micke, Irma Fredriksson, Aglaia Schiza
Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study. Breast cancer research and treatment 207 (2) (2024)
Carina Strell, Daniel Robert Smith, Antonis Valachis, Hellén Woldeyesus, Charlotta Wadsten, Patrick Micke, Irma Fredriksson, Aglaia Schiza
Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study. Breast cancer research and treatment 207 (2) (2024)
Carina Strell, Daniel Robert Smith, Antonis Valachis, Hellén Woldeyesus, Charlotta Wadsten, Patrick Micke, Irma Fredriksson, Aglaia Schiza
Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study. Breast cancer research and treatment 207 (2) (2024)
Aglaia Schiza, Irma Fredriksson, Malin Sund, Antonios Valachis
Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study. Breast cancer research and treatment (2023)
Aglaia Schiza, Irma Fredriksson, Malin Sund, Antonios Valachis
De Novo metastatic breast cancer in males versus females: a Swedish, population-based cohort study. JNCI cancer spectrum (2023)
Aglaia Schiza, Davide Mauri, Irma Fredriksson, null Anna-Karin Wennstig, Antonios Valachis
Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study. Breast cancer research and treatment 186 (3) (2020)
Aglaia Schiza, Sandra Irenaeus, Francisco Ortiz-Nieto, Angelica Loskog, Thomas Tötterman, Anders Sundin, Gustav J Ullenhag, Håkan Ahlström
Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients. Scientific reports 9 (1) (2019)